Old Port Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,125
Closed -$210K 222
2021
Q2
$210K Buy
+1,125
New +$193K 0.08% 213
2021
Q1
Sell
-1,391
Closed -$218K 221
2020
Q4
$218K Sell
1,391
-527
-27% -$67.7K 0.09% 173
2020
Q3
$219K Sell
1,918
-21
-1% -$2.27K 0.11% 160
2020
Q2
$218K Buy
+1,939
New +$206K 0.11% 158

Other funds holding ALXN

Old Port Advisors's ALXN Position: Q3 2021 in Review

Old Port Advisors sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 1,125 shares — an estimated $210K sold.

Old Port Advisors first reported a position in ALXN in Q2 2020 and held it in 4 quarters. The position peaked at $219K in Q3 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Old Port Advisors reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Old Port Advisors sold 1,125 Alexion Pharmaceuticals shares in Q3 2021, an estimated $210K.
  • Old Port Advisors first reported a position in Alexion Pharmaceuticals in Q2 2020 and held it in 4 quarters.
  • Old Port Advisors's Alexion Pharmaceuticals position peaked at $219K in Q3 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Old Port Advisors's 13F filing for Q3 2021, filed 12 Oct 2021.